List of Figures:
Figure 3-1: Worldwide - Pharmaceutical Market Revenue (in Billion US$), 2001-2005
Figure 3-2: Worldwide - Pharmaceutical Market by Therapeutic Segmentation (%), 2004
Figure 3-3: Worldwide - Pharmaceutical Market Segment by Region (%), 2004
Figure 3-4: Worldwide - Annual Pharmaceutical Expenditure/Head by Country (in US$), 2003
Figure 4-1: Worldwide - Growth in Biologics Market (in Billion US$), 2004 & 2005
Figure 4-2: Worldwide - Over the Counter Products Sales (in Billion US$), 2001-2005
Figure 4-3: India - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-4: China - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-5: China - Population Aged above 65 Years (%), 2006-2011
Figure 4-6: China - GDP Growth (in Trillion US$), 2001-2011E
Figure 4-7: Australia - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-8: Australia - Pharmaceutical Expenditure by Government (in Billion Aus$), 2001-2003
Figure 4-9: Japan - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-10: Indonesia - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-11: Hong Kong - Pharmaceutical Sales Market (in Million US$), 2000-2005
Figure 4-12: South Korea - Pharmaceutical Market Revenue (in Billion US$), 2001-2005
Figure 4-13: United Kingdom - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-14: France - Generic Drugs Sale (in Million US$), 2000-2004
Figure 4-15: France - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-16: Germany - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-17: Germany - Increase in Life Expectancy (in Year), 2006-2010
Figure 4-18: Germany - Forecast of Pharmaceutical Sales (in Billion US$), 2006-2010
Figure 4-19: Mexico - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-20: Brazil - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-21: Chile - Pharmaceutical Sales Market (in Million US$), 2001-2005
Figure 4-22: USA - Pharmaceutical Sales Market (in Billion US$), 2001-2005
Figure 4-23: USA - Forecast of Clinical Trial Business (in Billion US$), 2006-2011
Figure 4-24: Canada - Pharmaceutical Sales Market (in Billion US$), 2000-2005
Figure 4-25: South Africa - Pharmaceutical Market Revenue (in Billion US$), 2001-2005
Figure 5-1: Worldwide - Average Life Expectancy (in Year), 2001-2005
Figure 5-2: Worldwide - Annual Spending in Healthcare (in US$/Head), 2001-2005
Figure 5-3: Worldwide - Number of Block Buster Drugs (2000 & 2005)
Figure 5-4: Worldwide - Growth in Over the Counter Drugs Sale (in Billion US$), 2004 & 2005
Figure 6-1: Worldwide - Forecast of Clinical Trial Market (in Billion US$), 2006 & 2007
Figure 6-2: Worldwide - Forecast for Enzyme Inhibitor Market (in Billion US$), 2006-2011
Figure 6-3: Worldwide - Forecast for Plant Derived Drugs & Applications Market (in Billion US$), 2006-2011
Figure 6-4: Worldwide - Growth in Plant Derived Drugs Sale (in Billion US$), 2005, 2006 & 2011
Figure 6-5: Worldwide - Growth of Influenza Therapeutics Market (in Billion US$), 2006-2010
Figure 6-6: Worldwide - Growth of Pharmacogenomics Market (in Billion US$), 2006-2009
Figure 6-7: Worldwide - Growth of Contract Manufacturing (in Billion US$), 2006-2009
Figure 6-8: Worldwide - Forecast of Anti-infective Market (in Billion US$), 2006-2010
Figure 7-1: Worldwide - Forecast of Pharmaceutical Market (in Billion US$), 2006-2010
Figure 7-2: Worldwide - Application Market for RFID Technology in Pharmaceutical Industry (in Billion US$), 2006-2011
Figure 8-1: GlaxoSmithKline - Stock Performance
Figure 8-2: AstraZeneca - Stock Performance
Figure 8-3: Johnson & Johnson - Stock Performance
Figure 8-4: Roche - Stock Performance
Figure 8-5: Merck & Co. - Stock Performance
Figure 8-6: Norvatis - Stock Performance
Figure 8-7: Wyeth - Stock Performance
Figure 8-8: Bristol-Myers Squibb - Stock Performance
Figure 8-9: Ranbaxy Laboratories Ltd. - Stock Performance
List of Tables:
Table 4-1: Worldwide - Pharmaceutical Sales by Top 10 Vendors (in Billion US$), 2005
Table 4-2: Worldwide - Pharmaceutical Sales by Major Therapy Classes (in Billion US$), 2005
Table 4-3: Worldwide - Pharmaceutical Sales by Leading Product Category (in Billion US$), 2005
Table 4-4: Worldwide - Over the Counter Drugs Sale by Therapy Classes (in Billion US$), 2005
Table 4-5: Worldwide - Over the Counter Drugs Market by Company (in Billion US$), 2005
Table 8-1: GlaxoSmithKline - Key Financial Overview (in Million US$), 2001-2005
Table 8-2: AstraZeneca - Key Financial Overview (in Million US$), 2005 & 2006
Table 8-3: Johnson & Johnson - Key Financial Overview (in Million US$), 2003-2005
Table 8-4: Roche - Key Financial Overview (in Million US$), 2005
Table 8-5: Merck & Co. - Key Financial Overview (in Million US$), 2003-2005
Table 8-6: Novartis - Key Financial Overview (in Million US$), 2001-2005
Table 8-7: Wyeth - Key Financial Overview (in Million US$), 2001-2005
Table 8-8: Bristol-Myers Squibb - Key Financial Overview (in Million US$), 2001-2005
Table 8-9: Ranbaxy Laboratories Ltd. - Key Financial Overview (in Million US$), 2002-2004
.jpg)
